2008
DOI: 10.1007/s11239-008-0215-0
|View full text |Cite
|
Sign up to set email alerts
|

Prothrombotic roles of substance-P, neurokinin-1 receptors and leukocytes in the platelet-dependent clot formation in whole blood

Abstract: A number of types of non-neuronal cells including leukocytes have been confirmed to possess substance-P and its specific neurokinin-1 receptor (NK1R), while the pathophysiological roles of substance-P in these cells remain to be established. Effects of substance-P through NK1R on platelet-dependent clot formation were evaluated by using an oscillating-probe viscoelastometer. The clot signal, indicative of the clot strength in blood-derived samples, was measured after the stimulation with celite and Ca(2+). Sub… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2010
2010
2020
2020

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 26 publications
(39 reference statements)
0
3
0
Order By: Relevance
“…A number of different types of non-neuronal cells including lymphocytes and monocytes possess SP and its specific NK1-R(Marriotte et al, 2001); however, the pathophysiological roles of SP in these cells remain to be established SP promotes platelet-dependent clot formation through NK1-R, in which leukocytes are involved (Azma et al, 2009). SP triggers functional responses in many cells of the immune system through NK1-R including inflammatory processes and immunologic responses, involving monocytes, macrophages, lymphocytes, microglia, natural killer cells, and precursors of immune cells (Douglas et al, 2011; Lai et al, 1998; Ho et al, 2002; Ho et al, 1997).…”
Section: Discussionmentioning
confidence: 99%
“…A number of different types of non-neuronal cells including lymphocytes and monocytes possess SP and its specific NK1-R(Marriotte et al, 2001); however, the pathophysiological roles of SP in these cells remain to be established SP promotes platelet-dependent clot formation through NK1-R, in which leukocytes are involved (Azma et al, 2009). SP triggers functional responses in many cells of the immune system through NK1-R including inflammatory processes and immunologic responses, involving monocytes, macrophages, lymphocytes, microglia, natural killer cells, and precursors of immune cells (Douglas et al, 2011; Lai et al, 1998; Ho et al, 2002; Ho et al, 1997).…”
Section: Discussionmentioning
confidence: 99%
“…C5a activation of mast cells stimulates production of plasminogen activator inhibitor (PAI)-1 and antagonizes t-PA production (Wojta et al, 2002), suggesting that additional mast cell activators, such as thrombin (Theoharides et al, 2011) and SP (Hermans et al, 2018), may have similar effects. SP also induces monocyte tissue factor expression (Khan et al, 2012) and promotes platelet clot formation (Azma et al, 2009). Understanding SP binding interactions with NK1 (Johnson et al, 2016) and Mas-related receptors (Green et al, 2019) on monocytes, mast cells and platelets may therefore be important hemostatic regulators in COVID-19 patients.…”
Section: Sars-cov-2 and Coagulationmentioning
confidence: 99%
“…The concentration of this drug was required to inhibit the function of NK1R in vivo as previously described. 12…”
Section: Inhibition Study By Neurokinin Receptor Antagonistmentioning
confidence: 99%